Ancestry of African Americans with sickle cell disease

Department of Biostatistics, Boston University School of Public Health, Boston, MA 02118, USA.
Blood Cells Molecules and Diseases (Impact Factor: 2.65). 06/2011; 47(1):41-5. DOI: 10.1016/j.bcmd.2011.04.002
Source: PubMed


The inheritance of genetic disease depends on ancestry that must be considered when interpreting genetic association studies and can provide insights when comparing traits in a population. We compared the genetic profiles of African Americans with sickle cell disease to those of Black Africans and Caucasian populations of European descent and found that they are less genetically admixed than other African Americans and have an ancestry similar to Yorubans, Mandenkas and Bantu.

Download full-text


Available from: Paola Sebastiani, Oct 06, 2015
26 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The degree of fetal hemoglobin (HbF) expression is a major determinant of phenotypic severity of sickle cell disease (SCD). Genetic regulation of HbF production is complex and can vary among ethnic groups. The pediatric sickle cell population at our institution is approximately half Hispanic, nearly all from the Dominican Republic. Hydroxyurea (HU) is the only Food and Drug Administration (FDA)-approved drug to ameliorate symptoms of SCD. We retrospectively compared baseline and HU-induced percent HbF (%HbF) in African American (AA) and Hispanic (H) patients aged 4 to 21 years with homozygous Sickle hemoglobin or HbSβ(0)Thalassemia. No significant differences were detected in average baseline %HbF between AA (N=48) and H (N=58) patients (P=0.63). In the subset of children taking HU who reached maximum tolerated dose (MTD), no differences were found between the ethnic groups in laboratory response to drug, measured by %HbF at MTD (P=0.28), the increase in %HbF (P=0.31) or mean red cell volume (MCV) (P=0.93), or the MTD of HU (P=0.95). Regulation of HbF at baseline and in response to HU are comparable between Hispanics and African Americans at our center. If generalizable, our results support combining these 2 groups in future clinical and translational analyses focused on HbF and response to HU in this ethnically mixed patient population.
    Journal of Pediatric Hematology/Oncology 10/2011; 33(7):496-9. DOI:10.1097/MPH.0b013e31822dcc21 · 0.90 Impact Factor
  • Blood 10/2011; 118(16):4495-6. DOI:10.1182/blood-2011-08-373928 · 10.45 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objectives: The purpose of this prospective study was to characterize the MR relaxometric features of the major salivary glands in patients with sickle cell disease (SCD). Methods: 15 patients with SCD (aged 19.8-43.6 years) and 12 controls were imaged with the mixed turbo-spin echo pulse sequence. The major salivary glands were manually segmented and T1, T2 and secular T2 relaxometry histograms were modelled with Gaussian functions. Results: Shortened T1 relaxation times were seen solely in the submandibular glands of patients with SCD (747.5±54.8 ms vs 807.1±38.3 ms, p<0.001). Slight T2 and secular T2 shortening were seen in the parotid gland; however, this difference was not significant (p=0.07). The sublingual gland showed no changes under MR relaxometry. There was no difference in glandular volumes, and no correlation was demonstrated between history of blood transfusion and salivary gland relaxometry. Conclusions: Patients with SCD exhibited changes in quantitative MRI T1 relaxometry histograms of the submandibular glands.
    Dentomaxillofacial Radiology 12/2012; 41(8):630-6. DOI:10.1259/dmfr/31672000 · 1.39 Impact Factor
Show more